Although GLP1-RA are cardioprotective in patients with T2D and high cardiovascular risk, recent studies showed that GLP1 levels were increased in patients with acute MI and were correlated with an adverse outcome and early events (Kahles et al., 2020). The gene discussed is GCG; the disease is type 2 diabetes mellitus.